Pfizer's Testosterone Drug Poses Heart Risks, Suit Says
Law360, New York (September 12, 2014, 7:31 PM EDT) -- Pfizer Inc. has become the latest target of allegations that testosterone treatments cause heart problems, with a new lawsuit accusing the drugmaker of promoting its Depo-Testosterone treatment as safe and effective despite its risks of causing heart attacks, strokes and blood clots.
Pfizer and its unit Pharmacia & Upjohn Co. LLC are accused of conducting a "disease mongering" campaign to exaggerate the prevalence of testosterone products in order to boost sales of Depo-Testosterone, despite its heart health risks, according to the Sept. 5 complaint brought by Alvaro Roman Gutierrez. The plaintiff claims his use of the drug caused him serious physical...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!